These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4780895)

  • 1. A pilot study of leprosy treatment with a combination of various antileprosy drugs. Preliminary report.
    Blenska W; Kolakowska E
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:26-31. PubMed ID: 4780895
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of a new antimycobacterial combined therapy in leprosy in East Africa].
    Verhagen AR
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:36-9. PubMed ID: 4780896
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the bacteriological effect of combined treatment with rifadin, sulfamethoxypyrazine, and isoniazide in lepromatous leprosy.
    Leiber DL; Verhagen AR
    Z Tropenmed Parasitol; 1973 Dec; 24():32-5. PubMed ID: 4592434
    [No Abstract]   [Full Text] [Related]  

  • 4. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
    Freerksen E; Rosenfeld M
    Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial clinical results using new, experimentally developed therapeutic forms in leprosy].
    Rohde R
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:40-52. PubMed ID: 4592436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
    Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamental data, methods and goals of present research on the treatment of leprosy.
    Freerksen E; Rosenfeld M
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:17-25. PubMed ID: 4592435
    [No Abstract]   [Full Text] [Related]  

  • 9. The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice.
    Hilson GR; Banerjee DK; Holmes IB
    Int J Lepr Other Mycobact Dis; 1971; 39(2):349-53. PubMed ID: 5169803
    [No Abstract]   [Full Text] [Related]  

  • 10. Whither the roles of rifater and rifamate?
    McConville JH
    Pa Med; 1996 Mar; 99(3):24-5. PubMed ID: 8692580
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Rifampicin.
    Med J Aust; 1973 Nov; 2(19):876. PubMed ID: 4765871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 13. The leprosy eradication-project of Malta.
    Agius-Ferrante A; Depasquale G; Bonnici E; Paris C; Grima W
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:49-52. PubMed ID: 4780897
    [No Abstract]   [Full Text] [Related]  

  • 14. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
    Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W
    Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008.
    Tochon M; Bosdure E; Salles M; Beloncle C; Chadelat K; Dagorne M; Gaudelus J; Losi S; Renoux MC; Veziris N; Dubus JC
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):326-30. PubMed ID: 21333098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lupus vulgaris. Treatment with 3 drugs].
    Palomo Arellano A; Celdrán Gil J; Marcos Sánchez F; Zapata Ingelmo A; Durán Pérez Navarro A
    An Med Interna; 1995 Jan; 12(1):31-2. PubMed ID: 7718716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 19. [Short-term clinical and histological evaluation of combination drug therapy of leprosy in Mayotte].
    Cnudde F; Julvez J; Rivière JP
    Acta Leprol; 1987; 5(2):115-24. PubMed ID: 3303804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR; Gatt P
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.